The Cbl family of proteins act as E3 ubiquitin-protein ligases and have been associated with the down regulation of a variety of receptor tyrosine kinsases. Cbl proteins associate with many different cell signalling molecules suggesting that they may have functions outside of the RING ®nger-mediated ubiquitin ligase activity. The Drosophila melanogaster cbl gene (D-cbl) encodes two splice forms (Oncogene 19 (2000) 3299). Here we report on the differential expression of these isoforms during Drosophila embryogenesis. Both isoforms are maternally expressed but the long isoform of D-cbl is also transiently expressed in the invaginating mesoderm and later is speci®cally expressed in neurons of the central nervous system (CNS). Cbl protein is shown to be localised to axons of the longitudinal connectives and commissures in the central nervous system. q
The prototypical member of the Cbl family, c-Cbl, was originally identi®ed following the discovery of a truncated form of the protein (v-Cbl) encoded by an oncogenic murine retrovirus . Subsequently, multiple genes encoding Cbl proteins have been discovered in vertebrates with single genes identi®ed in Caenorhabditis elegans and Drosophila melanogaster (Hime et al., 1997; Keane et al., 1995 Keane et al., , 1999 Meisner et al., 1997; Regnier et al., 1989; Yoon et al., 1995) . Three Cbl genes have been identi®ed in mammals to date (c-Cbl, Cbl-b and Cbl-3). cCbl and Cbl-b each contain an N-terminal SH2-like phosphotyrosine-binding domain, a RING ®nger, an SH3-binding region and a C-terminal UBA domain. Cbl-3 and the C. elegans homologue, SLI-1 are both truncated with respect to c-Cbl and do not contain a UBA domain. The Drosophila cbl gene encodes two splice forms, a shorter protein that ends soon after the RING ®nger (D-CblS) and a longer isoform that contains an SH3-binding region and a UBA domain (D-CblL) similar to mammalian c-Cbl (Fig. 1A,B ) (Robertson et al., 2000) . Although D-cbl has been shown to play a role in regulating EGF receptor activity (Pai et al., 2000) the differential functions of the isoforms remain unknown.
Results and discussion
To begin to examine if the two Drosophila Cbl proteins have distinct roles in development we sought to determine if the isoforms are differentially expressed in the embryo. As the two mRNA isoforms have different 3 H untranslated regions we were able to generate isoform speci®c antisense riboprobes (Fig. 1A) . We also generated rabbit antisera to two regions of D-Cbl. Antiserum GH2 was generated against a glutathione S-transferase:: D-CblS fusion protein and GH6 against a region of the D-CblL speci®c exon fused to GST (Fig. 1B) . GH2 immunoprecipitated both D-CblS and D-CblL from in vitro translated proteins and GH6 speci®cally precipitated D-CblL (Fig. 1C ). We were unable to detect D-CblL expression in vivo using GH6 so subsequent immunolocalisation was conducted using GH2. Western blots of lysates from S2 cells expressing enhanced yellow uorescent protein (YFP) alone and a D-CblS::YFP fusion protein showed that GH2 could speci®cally detect the fusion protein (Fig. 1D ).
D-cblS is only highly expressed until cellular blastoderm formation
D-cblS is strongly maternally expressed with high levels of mRNA in preblastoderm embryos ( Fig. 2A) . A concen- tration of D-cblS mRNA was observed at the posterior pole of several preblastoderm embryos (Fig. 2B) , although high levels were not observed in pole cells (Fig. 2C) . D-cblS mRNA remains at high levels up until cellular blastoderm when it begins to be degraded (Fig. 2C) . Subsequently, only a low level of expression is observed throughout the later stages of embryogenesis, for example (Fig. 2D) . The level of expression is signi®cantly higher than background levels detected with a sense-strand riboprobe (Figs. 2E,F) and may re¯ect low level zygotic expression.
D-cblL has a dynamic expression pattern during early embryogenesis and neurogenesis
A high level of maternal D-cblL expression is present analogous to D-cblS (Fig. 2G) . In contrast to D-cblS, DcblL mRNA is completely absent by cellular blastoderm stage (Fig. 2H) . No association with the posterior pole is evident. D-cblL is ®rst zygotically expressed during gastrulation in invaginating mesoderm (Fig. 2I) . This expression is, however, transient and rapidly downregulated postgastrulation. A low level of expression is present in germband extended embryos (Fig. 2J) . D-cblL is next observed in stage 11 embryos in the CNS. Expression is speci®c to developing neurons (Fig. 2K,L) with no evidence of expression in more ventral layers of the nerve cord (i.e. neuroblasts). Levels of D-cblL mRNA remain relatively constant but more cells of the ventral nerve cord are observed to express D-cblL as the nervous system develops (Fig. 2 M,N) . In stage 15/16 embryos D-cblL is widely expressed in the ventral nerve cord (Fig. 2N,O) and brain (Fig. 2P ).
D-Cbl protein is localised to axons of the central nervous system
We used the GH2 antisera to examine localisation of DCbl protein within the CNS. In stage 13 embryos a low level of staining is evident across all cells of the embryo (Fig.  3A) . This probably re¯ects the low level zygotic expression of D-cblS observed from mRNA in situ hybridisation. A higher level of expression is present in the longitudinal connectives of the CNS (Fig. 3A,B) . Expression is also observed in axons of the brain (Fig. 3C) . The mRNA in situ data would suggest that we are observing axonal localisation of D-CblL. Axon staining is more intense in stage 16 embryos (Fig. 3G,H,I ). Dissection of the CNS from a stage 16 embryo shows that D-Cbl protein is localised to the commissures as well as the longitudinal connectives (Fig.  3M) , suggesting that most CNS axons express the protein.
Methods
Immunoprecipitations and western blots were performed according to (Rozakis-Adcock et al., 1993) except that western blots were washed in Tris-buffered saline 1 0.05% Tween. mRNA in situ hybridsations and immunohistochemistry were performed according to (Lehmann and Tautz, 1994) and (Patel, 1994) respectively. D-Cbl antisera were pre-absorbed against ®xed embryos and used at 1:60 000 for westerns and 1:6000 for immunohistochemistry. Rabbit polyclonal anti-GFP (detects YFP) was used at 1:100. S2 cell expression was conducted using pAc5.1/V5-HisA (Invitrogen).
